{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:18:23Z","timestamp":1791224303936,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T00:00:00Z","timestamp":1361145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T00:00:00Z","timestamp":1361145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2014,2,13]]},"DOI":"10.1038\/onc.2013.12","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T14:36:19Z","timestamp":1361198179000},"page":"872-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["KIT-D816V oncogenic activity is controlled by the juxtamembrane docking site Y568-Y570"],"prefix":"10.1038","volume":"33","author":[{"given":"A","family":"Chaix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-L","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Voisset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Letard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Audebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Finetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Birnbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Bertucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Aurrand-Lions","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Dubreuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"De Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,2,18]]},"reference":[{"key":"BFonc201312_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1126\/science.279.5350.577","volume":"279","author":"S Hirota","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577\u2013580.","journal-title":"Science"},{"key":"BFonc201312_CR2","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","volume":"96","author":"BJ Longley","year":"1999","unstructured":"Longley BJ, Metcalfe DD, Tharp M, Wang X, Tyrrell L, Lu SZ et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999; 96: 1609\u20131614.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201312_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10428190400010775","volume":"46","author":"P Valent","year":"2005","unstructured":"Valent P, Akin C, Sperr WR, Mayerhofer M, Fodinger M, Fritsche-Polanz R et al. Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma 2005; 46: 35\u201348.","journal-title":"Leuk Lymphoma"},{"key":"BFonc201312_CR4","first-page":"920","volume":"89","author":"A Beghini","year":"2004","unstructured":"Beghini A, Ripamonti CB, Cairoli R, Cazzaniga G, Colapietro P, Elice F et al. KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication. Haematologica 2004; 89: 920\u2013925.","journal-title":"Haematologica"},{"key":"BFonc201312_CR5","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1182\/blood-2005-09-3640","volume":"107","author":"R Cairoli","year":"2006","unstructured":"Cairoli R, Beghini A, Grillo G, Nadali G, Elice F, Ripamonti CB et al. Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood 2006; 107: 3463\u20133468.","journal-title":"Blood"},{"key":"BFonc201312_CR6","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC . Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340\u20134346.","journal-title":"J Clin Oncol"},{"key":"BFonc201312_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0002-9440(10)63120-3","volume":"164","author":"K Kemmer","year":"2004","unstructured":"Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D et al. KIT mutations are common in testicular seminomas. Am J Pathol 2004; 164: 305\u2013313.","journal-title":"Am J Pathol"},{"key":"BFonc201312_CR8","first-page":"7674","volume":"63","author":"LH Looijenga","year":"2003","unstructured":"Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ et al. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 2003; 63: 7674\u20137678.","journal-title":"Cancer Res"},{"key":"BFonc201312_CR9","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/S0002-9440(10)65419-3","volume":"154","author":"Q Tian","year":"1999","unstructured":"Tian Q, Frierson HF, Krystal GW, Moskaluk CA . Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 1999; 154: 1643\u20131647.","journal-title":"Am J Pathol"},{"key":"BFonc201312_CR10","first-page":"2345","volume":"60","author":"T Hongyo","year":"2000","unstructured":"Hongyo T, Li T, Syaifudin M, Baskar R, Ikeda H, Kanakura Y et al. Specific c-kit mutations in sinonasal natural killer\/T-cell lymphoma in China and Japan. Cancer Res 2000; 60: 2345\u20132347.","journal-title":"Cancer Res"},{"key":"BFonc201312_CR11","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","volume":"113","author":"KH Lim","year":"2009","unstructured":"Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009; 113: 5727\u20135736.","journal-title":"Blood"},{"key":"BFonc201312_CR12","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1128\/MCB.23.9.3067-3078.2003","volume":"23","author":"PM Chan","year":"2003","unstructured":"Chan PM, Ilangumaran S, La Rose J, Chakrabartty A, Rottapel R . Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region. Mol Cell Biol 2003; 23: 3067\u20133078.","journal-title":"Mol Cell Biol"},{"key":"BFonc201312_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.cell.2007.05.055","volume":"130","author":"S Yuzawa","year":"2007","unstructured":"Yuzawa S, Opatowsky Y, Zhang Z, Mandiyan V, Lax I, Schlessinger J . Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell 2007; 130: 323\u2013334.","journal-title":"Cell"},{"key":"BFonc201312_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/jid.2009.281","volume":"130","author":"C Bodemer","year":"2010","unstructured":"Bodemer C, Hermine O, Palmerini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol 2010; 130: 804\u2013815.","journal-title":"J Invest Dermatol"},{"key":"BFonc201312_CR15","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/sj.leu.2403870","volume":"19","author":"BF Goemans","year":"2005","unstructured":"Goemans BF, Zwaan CM, Miller M, Zimmermann M, Harlow A, Meshinchi S et al. Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia. Leukemia 2005; 19: 1536\u20131542.","journal-title":"Leukemia"},{"key":"BFonc201312_CR16","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1182\/blood-2009-06-226027","volume":"116","author":"Y Yang","year":"2010","unstructured":"Yang Y, Letard S, Borge L, Chaix A, Hanssens K, Lopez S et al. Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. Blood 2010; 116: 1114\u20131123.","journal-title":"Blood"},{"key":"BFonc201312_CR17","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.4049\/jimmunol.180.8.5466","volume":"180","author":"M Mayerhofer","year":"2008","unstructured":"Mayerhofer M, Gleixner KV, Hoelbl A, Florian S, Hoermann G, Aichberger KJ et al. Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. J Immunol 2008; 180: 5466\u20135476.","journal-title":"J Immunol"},{"key":"BFonc201312_CR18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20050807","volume":"202","author":"JP Zappulla","year":"2005","unstructured":"Zappulla JP, Dubreuil P, Desbois S, Letard S, Hamouda NB, Daeron M et al. Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. J Exp Med 2005; 202: 1635\u20131641.","journal-title":"J Exp Med"},{"key":"BFonc201312_CR19","doi-asserted-by":"publisher","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-05-0891","volume":"65","author":"BP Rubin","year":"2005","unstructured":"Rubin BP, Antonescu CR, Scott-Browne JP, Comstock ML, Gu Y, Tanas MR et al. A knock-in mouse model of gastrointestinal stromal tumor harboring kit K641E. Cancer Res 2005; 65: 6631\u20136639.","journal-title":"Cancer Res"},{"key":"BFonc201312_CR20","doi-asserted-by":"publisher","first-page":"6706","DOI":"10.1073\/pnas.1037763100","volume":"100","author":"G Sommer","year":"2003","unstructured":"Sommer G, Agosti V, Ehlers I, Rossi F, Corbacioglu S, Farkas J et al. Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase. Proc Natl Acad Sci USA 2003; 100: 6706\u20136711.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201312_CR21","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1038\/sj.onc.1206587","volume":"22","author":"N Casteran","year":"2003","unstructured":"Casteran N, De Sepulveda P, Beslu N, Aoubala M, Letard S, Lecocq E et al. Signal transduction by several KIT juxtamembrane domain mutations. Oncogene 2003; 22: 4710\u20134722.","journal-title":"Oncogene"},{"key":"BFonc201312_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1084\/jem.20031983","volume":"199","author":"V Agosti","year":"2004","unstructured":"Agosti V, Corbacioglu S, Ehlers I, Waskow C, Sommer G, Berrozpe G et al. Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J Exp Med 2004; 199: 867\u2013878.","journal-title":"J Exp Med"},{"key":"BFonc201312_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.exphem.2008.10.009","volume":"37","author":"V Agosti","year":"2009","unstructured":"Agosti V, Karur V, Sathyanarayana P, Besmer P, Wojchowski DM . A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis. Exp Hematol 2009; 37: 159\u2013171.","journal-title":"Exp Hematol"},{"key":"BFonc201312_CR24","doi-asserted-by":"publisher","first-page":"6015","DOI":"10.1073\/pnas.0305363101","volume":"101","author":"Y Kimura","year":"2004","unstructured":"Kimura Y, Jones N, Kluppel M, Hirashima M, Tachibana K, Cohn JB et al. Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc Natl Acad Sci USA 2004; 101: 6015\u20136020.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc201312_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bbrc.2010.01.116","volume":"393","author":"E Voisset","year":"2010","unstructured":"Voisset E, Lopez S, Chaix A, Vita M, George C, Dubreuil P et al. FES kinase participates in KIT-ligand induced chemotaxis. Biochem Biophys Res Commun 2010; 393: 174\u2013178.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFonc201312_CR26","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1128\/MCB.18.4.2089","volume":"18","author":"M Kozlowski","year":"1998","unstructured":"Kozlowski M, Larose L, Lee F, Le DM, Rottapel R, Siminovitch KA . SHP-1 binds and negatively modulates the c-Kit receptor by interaction with tyrosine 569 in the c-Kit juxtamembrane domain. Mol Cell Biol 1998; 18: 2089\u20132099.","journal-title":"Mol Cell Biol"},{"key":"BFonc201312_CR27","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1074\/jbc.272.9.5915","volume":"272","author":"DJ Price","year":"1997","unstructured":"Price DJ, Rivnay B, Fu Y, Jiang S, Avraham S, Avraham H . Direct association of Csk homologous kinase (CHK) with the diphosphorylated site Tyr568\/570 of the activated c-KIT in megakaryocytes. J Biol Chem 1997; 272: 5915\u20135920.","journal-title":"J Biol Chem"},{"key":"BFonc201312_CR28","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1182\/blood-2008-05-154849","volume":"112","author":"C Simon","year":"2008","unstructured":"Simon C, Dondi E, Chaix A, de Sepulveda P, Kubiseski TJ, Varin-Blank N et al. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells. Blood 2008; 112: 4039\u20134047.","journal-title":"Blood"},{"key":"BFonc201312_CR29","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1158\/1541-7786.MCR-09-0138","volume":"7","author":"H Bougherara","year":"2009","unstructured":"Bougherara H, Subra F, Crepin R, Tauc P, Auclair C, Poul MA . The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment. Mol Cancer Res 2009; 7: 1525\u20131533.","journal-title":"Mol Cancer Res"},{"key":"BFonc201312_CR30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/MCB.01153-06","volume":"27","author":"Z Xiang","year":"2007","unstructured":"Xiang Z, Kreisel F, Cain J, Colson A, Tomasson MH . Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling. Mol Cell Biol 2007; 27: 267\u2013282.","journal-title":"Mol Cell Biol"},{"key":"BFonc201312_CR31","doi-asserted-by":"publisher","first-page":"11686","DOI":"10.1074\/jbc.M207068200","volume":"278","author":"BL Tan","year":"2003","unstructured":"Tan BL, Hong L, Munugalavadla V, Kapur R . Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in Kit. Role for Src kinase pathway in Kit-induced cooperation with erythropoietin receptor. J Biol Chem 2003; 278: 11686\u201311695.","journal-title":"J Biol Chem"},{"key":"BFonc201312_CR32","doi-asserted-by":"publisher","first-page":"11039","DOI":"10.1074\/jbc.M808058200","volume":"284","author":"J Sun","year":"2009","unstructured":"Sun J, Pedersen M, Ronnstrand L . The D816V mutation of c-Kit circumvents a requirement for Src family kinases in c-Kit signal transduction. J Biol Chem 2009; 284: 11039\u201311047.","journal-title":"J Biol Chem"},{"key":"BFonc201312_CR33","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1128\/MCB.24.3.1401-1410.2004","volume":"24","author":"L Hong","year":"2004","unstructured":"Hong L, Munugalavadla V, Kapur R . c-Kit-mediated overlapping and unique functional and biochemical outcomes via diverse signaling pathways. Mol Cell Biol 2004; 24: 1401\u20131410.","journal-title":"Mol Cell Biol"},{"key":"BFonc201312_CR34","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.1182\/blood.V99.9.3342","volume":"99","author":"S Ueda","year":"2002","unstructured":"Ueda S, Mizuki M, Ikeda H, Tsujimura T, Matsumura I, Nakano K et al. Critical roles of c-Kit tyrosine residues 567 and 719 in stem cell factor-induced chemotaxis: contribution of src family kinase and PI3-kinase on calcium mobilization and cell migration. Blood 2002; 99: 3342\u20133349.","journal-title":"Blood"},{"key":"BFonc201312_CR35","doi-asserted-by":"publisher","first-page":"5956","DOI":"10.1074\/jbc.M110.182642","volume":"286","author":"A Chaix","year":"2011","unstructured":"Chaix A, Lopez S, Voisset E, Gros L, Dubreuil P, De Sepulveda P . Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells. J Biol Chem 2011; 286: 5956\u20135966.","journal-title":"J Biol Chem"},{"key":"BFonc201312_CR36","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.cellsig.2009.06.002","volume":"21","author":"K Masson","year":"2009","unstructured":"Masson K, Ronnstrand L . Oncogenic signaling from the hematopoietic growth factor receptors c-Kit and Flt3. Cell Signal 2009; 21: 1717\u20131726.","journal-title":"Cell Signal"},{"issue":"Pt 1","key":"BFonc201312_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1042\/bj3270073","volume":"327","author":"C Deberry","year":"1997","unstructured":"Deberry C, Mou S, Linnekin D . Stat1 associates with c-kit and is activated in response to stem cell factor. Biochem J 1997; 327 (Pt 1): 73\u201380.","journal-title":"Biochem J"},{"key":"BFonc201312_CR38","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.1074\/jbc.272.15.10248","volume":"272","author":"M Sattler","year":"1997","unstructured":"Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV et al. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL). J Biol Chem 1997; 272: 10248\u201310253.","journal-title":"J Biol Chem"},{"key":"BFonc201312_CR39","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1182\/blood-2007-02-076471","volume":"110","author":"E Voisset","year":"2007","unstructured":"Voisset E, Lopez S, Dubreuil P, De Sepulveda P . The tyrosine kinase FES is an essential effector of KITD816V proliferation signal. Blood 2007; 110: 2593\u20132599.","journal-title":"Blood"},{"key":"BFonc201312_CR40","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1038\/sj.onc.1202929","volume":"18","author":"J Lennartsson","year":"1999","unstructured":"Lennartsson J, Blume-Jensen P, Hermanson M, Ponten E, Carlberg M, Ronnstrand L . Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor\/c-kit mediated activation of the Ras\/MAP kinase pathway and c-fos induction. Oncogene 1999; 18: 5546\u20135553.","journal-title":"Oncogene"},{"key":"BFonc201312_CR41","doi-asserted-by":"publisher","first-page":"6250","DOI":"10.1093\/emboj\/17.21.6250","volume":"17","author":"I Timokhina","year":"1998","unstructured":"Timokhina I, Kissel H, Stella G, Besmer P . Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation. Embo J 1998; 17: 6250\u20136262.","journal-title":"Embo J"},{"key":"BFonc201312_CR42","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1182\/blood-2005-11-011429","volume":"108","author":"JL Rocnik","year":"2006","unstructured":"Rocnik JL, Okabe R, Yu JC, Lee BH, Giese N, Schenkein DP et al. Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD. Blood 2006; 108: 1339\u20131345.","journal-title":"Blood"},{"key":"BFonc201312_CR43","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1158\/1078-0432.CCR-07-1873","volume":"14","author":"S Vempati","year":"2008","unstructured":"Vempati S, Reindl C, Wolf U, Kern R, Petropoulos K, Naidu VM et al. Transformation by oncogenic mutants and ligand-dependent activation of FLT3 wild-type requires the tyrosine residues 589 and 591. Clin Cancer Res 2008; 14: 4437\u20134445.","journal-title":"Clin Cancer Res"},{"key":"BFonc201312_CR44","first-page":"1347","volume":"11","author":"HR Glover","year":"1995","unstructured":"Glover HR, Baker DA, Celetti A, Dibb NJ . Selection of activating mutations of c-fms in FDC-P1 cells. Oncogene 1995; 11: 1347\u20131356.","journal-title":"Oncogene"},{"key":"BFonc201312_CR45","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1158\/1541-7786.MCR-08-0169","volume":"6","author":"R Buettner","year":"2008","unstructured":"Buettner R, Mesa T, Vultur A, Lee F, Jove R . Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells. Mol Cancer Res 2008; 6: 1766\u20131774.","journal-title":"Mol Cancer Res"},{"key":"BFonc201312_CR46","doi-asserted-by":"publisher","first-page":"43254","DOI":"10.1074\/jbc.M405247200","volume":"279","author":"PM Lievens","year":"2004","unstructured":"Lievens PM, Mutinelli C, Baynes D, Liboi E . The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling. J Biol Chem 2004; 279: 43254\u201343260.","journal-title":"J Biol Chem"},{"key":"BFonc201312_CR47","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1128\/MCB.25.9.3690-3703.2005","volume":"25","author":"DE Schmidt-Arras","year":"2005","unstructured":"Schmidt-Arras DE, Bohmer A, Markova B, Choudhary C, Serve H, Bohmer FD . Tyrosine phosphorylation regulates maturation of receptor tyrosine kinases. Mol Cell Biol 2005; 25: 3690\u20133703.","journal-title":"Mol Cell Biol"},{"key":"BFonc201312_CR48","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1172\/JCI116761","volume":"92","author":"T Furitsu","year":"1993","unstructured":"Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993; 92: 1736\u20131744.","journal-title":"J Clin Invest"},{"key":"BFonc201312_CR49","doi-asserted-by":"publisher","first-page":"12249","DOI":"10.1074\/jbc.M313381200","volume":"279","author":"J Bayle","year":"2004","unstructured":"Bayle J, Letard S, Frank R, Dubreuil P, De Sepulveda P . Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling. J Biol Chem 2004; 279: 12249\u201312259.","journal-title":"J Biol Chem"},{"key":"BFonc201312_CR50","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1021\/ac950914h","volume":"68","author":"A Shevchenko","year":"1996","unstructured":"Shevchenko A, Wilm M, Vorm O, Mann M . Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850\u2013858.","journal-title":"Anal Chem"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc201312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201312","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc201312.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:46:37Z","timestamp":1647891997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc201312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,18]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,2,13]]}},"alternative-id":["BFonc201312"],"URL":"https:\/\/doi.org\/10.1038\/onc.2013.12","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,18]]},"assertion":[{"value":"18 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}